Clinical trial
Evaluate the Efficacy and Safety of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients Who Pretreated With Tenofovir Disoproxil Fumarate
NCT03485534 is registered in ClinicalTrials.gov with Daewoong Pharmaceutical Co. LTD. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluate the Efficacy and Safety of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients Who Pretreated With Tenofovir Disoproxil Fumarate
- Lead sponsor
- Daewoong Pharmaceutical Co. LTD.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 23, 2018
- Completion date
- November 4, 2019
- Enrollment
- 189 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.